Sigma-Aldrich Posts 2 Percent Q4 Revenue Growth | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported a 2 percent increase in fourth quarter revenues to $582 million, a new quarterly high, but short of analysts' expectations.

The figure for the three months ended Dec. 31, 2010, compares to $573 million for the fourth quarter of 2009. Wall Street expected revenues for the quarter of $587.5 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.